RxDoctor Payments Data

Michael Kaplan, MD

Sports Medicine · Middlebury, CTNPI 1124047196

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $371,279 of the $385,195 with a category attached, or 96.4%. Encore Medical, LP accounts for 96.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $108,802 and has fallen 100.0% since, to $48 in 2024. Among sports medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$385,195in general payments, 2019–2025

Across 81 payments — averaging $4755.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$372K
  • EMD Serono, Inc.$8K
  • Celularity Inc.$2K
  • Smith+Nephew$2K
  • KCI USA, Inc.$493
  • Amgen$137
  • plus $315 from 8 others

What the payments were for

  • Royalty or licence$371,27996%
  • Consulting fees$2,2001%
  • Speaking & faculty fees$6,9002%
  • Travel & lodging$2,8691%
  • Food & beverage$1,9471%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$385,195 in reported general payments places this provider in the 95th percentile of 65 sports medicine providers in Connecticut.

See all sports medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$152,800
Medicare patients
349
Services billed
6,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib17$1,075
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$274
Oxycodone Hcl17$160
Ondansetron OdtOndansetron26$124
Amoxicillin60$102
Tramadol Hcl11$46
Meloxicam14$39

Paid to pharmacies, not to this prescriber.

Other sports medicine in Middlebury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →